The use of procalcitonin (PCT) has grown over the past decade with increasing reliance on the test to rule out bacterial infection. We retrospectively reviewed the medical records of children <18 years old hospitalized at a tertiary care children’s hospital from 2017 to 2019 who had PCT testing performed during their admission. Of 4135 PCT levels collected on 1530 children, 982 (23.7%) were diagnostically low and 1993 (48.1%) were diagnostically elevated. Pediatric intensive care, with 6% of total hospital patients, obtained 41.4% of tests. Thirty-one (2%) patients had an average of 27 PCT levels per patient, accounting for 20% of all tests. Many children had symptoms for which testing is not indicated (eg, skin complaints). The differences in PCT testing by service, inappropriate patterns of repeat testing, and testing performed in patients for whom it is not indicated may identify targets for diagnostic stewardship.
StockerMvan HerkWEl HelouS, et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet. 2017;390(10097):871-881.
2.
EspositoSTagliabueCPicciolliI, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respir Med. 2011;105(12):1939-1945.
3.
Galetto-LacourAZamoraSAGervaixA. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics. 2003;112(5):1054-1060.
4.
GendrelDRaymondJCosteJ, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. Pediatr Infect Dis J. 1999;18(10):875-881.
5.
Fernández LopezALuaces CubellsCGarcíaJJFernández PouJ; Spanish Society of Pediatric Emerg-encies. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J. 2003;22(10):895-903.
6.
PratCDomínguezJRodrigoC, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J. 2003;22(11):963-968.
7.
HenryBMRoyJRamakrishnanPKVikseJTomaszewskiKAWalochaJA. Procalcitonin as a serum biomarker for differentiation of bacterial meningitis from viral meningitis in children: evidence from a meta-analysis. Clin Pediatr (Phila). 2016;55(8):749-764.
8.
GendrelDRaymondJAssicotM, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis. 1997;24(6):1240-1242.
9.
AlkholiUMAbd Al-MonemNAbd El-AzimAASultanMH. Serum procalcitonin in viral and bacterial meningitis. J Glob Infect Dis. 2011;3(1):14-18.
10.
DubosFKorczowskiBAygunDA, et al. Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. Arch Pediatr Adolesc Med. 2008;162(12):1157-1163.
BaumannPBaerGBonhoefferJ, et al. Procalcitonin for diagnostics and treatment decisions in pediatric lower respiratory tract infections. Front Pediatr. 2017;5:183.
13.
DonMValentFKorppiM, et al. Efficacy of serum procalcitonin in evaluating severity of community-acquired pneumonia in childhood. Scand J Infect Dis. 2007;39(2):129-137.
14.
ChoIRDoMYHanSYJangSIChoJH. Comparison of Interleukin-6, C-reactive protein, procalcitonin, and the computed tomography severity index for early prediction of severity of acute pancreatitis. Gut Liver. 2023;17:629-637.
15.
BrindleRJIjazADaviesP. Procalcitonin and cellulitis: correlation of procalcitonin blood levels with measurements of severity and outcome in patients with limb cellulitis. Biomarkers. 2019;24(2):127-130.
16.
WoodsCRBradleyJSChatterjeeA, et al. Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America: 2021 Guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics. J Pediatric Infect Dis Soc. 2021;10(8):801-844.
17.
JainAJenaAGautamVSamantaJSharmaVMandavdhareHS. Role of change in the levels of inflammatory markers post drainage in predicting outcome in acute cholangitis. Arq Gastroenterol. 2022;59(2):212-218.
18.
EnglandJTDel VecchioMTAronoffSC. Use of serum procalcitonin in evaluation of febrile infants: a meta-analysis of 2317 patients. J Emerg Med. 2014;47(6):682-688.
19.
WaterfieldTManeyJAHannaMFairleyDShieldsMD. Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study. BMC Pediatr. 2018;18(1):387.
20.
AhmedAMMohammedATBastawyS, et al. Serum biomarkers for the early detection of the early-onset neonatal sepsis: a single-center prospective study. Adv Neonatal Care. 2019;19(5):E26-E32.
21.
RuanLChenGYLiuZ, et al. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review. Crit Care. 2018;22(1):316.
22.
Pravin CharlesMVKalaivaniRVenkateshSKaliASeethaKS. Evaluation of procalcitonin as a diagnostic marker in neonatal sepsis. Indian J Pathol Microbiol. 2018;61(1):81-84.
23.
KumarNDayalRSinghP, et al. A comparative evaluation of presepsin with procalcitonin and CRP in diagnosing neonatal sepsis. Indian J Pediatr. 2019;86(2):177-179.
24.
RashwanNIHassanMHMohey El-DeenZMAhmedAE. Validity of biomarkers in screening for neonatal sepsis—a single center -hospital based study. Pediatr Neonatol. 2019;60(2):149-155.
25.
EschbornSWeitkampJH. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis. J Perinatol. 2019;39(7):893-903.
26.
PontrelliGDe CrescenzoFBuzzettiR, et al. Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis. BMC Infect Dis. 2017;17(1):302.
27.
LeeISParkYJJinMH, et al. Usefulness of the procalcitonin test in young febrile infants between 1 and 3 months of age. Korean J Pediatr. 2018;61(9):285-290.
28.
MilcentKFaeschSGras-Le GuenC, et al. Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr. 2016;170(1):62-69.
29.
VelascoRGómezBHernández-BouS, et al. Validation of a predictive model for identifying febrile young infants with altered urinalysis at low risk of invasive bacterial infection. Eur J Clin Microbiol Infect Dis. 2017;36(2):281-284.
30.
KuppermannNDayanPSLevineDA, et al. A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections. JAMA Pediatr. 2019;173(4):342-351.
31.
MintegiSGomezBMartinez-VirumbralesLMorientesOBenitoJ. Outpatient management of selected young febrile infants without antibiotics. Arch Dis Child. 2017;102(3):244-249.
32.
BressanSGomezBMintegiS, et al. Diagnostic performance of the lab-score in predicting severe and invasive bacterial infections in well-appearing young febrile infants. Pediatr Infect Dis J. 2012;31(12):1239-1244.
33.
PantellRHRobertsKBAdamsWG, et al. Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics. 2021;148(2):e2021052228.
34.
DubosFMoulinFGajdosV, et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr. 2006;149(1):72-76.
35.
IbrahimKAAbdel-WahabAAIbrahimAS. Diagnostic value of serum procalcitonin levels in children with meningitis: a comparison with blood leukocyte count and C-reactive protein. J Pak Med Assoc. 2011;61(4):346-351.
36.
KimHRohYHYoonSH. Blood procalcitonin level as a diagnostic marker of pediatric bacterial meningitis: a systematic review and meta-analysis. Diagnostics (Basel). 2021;11(5):846.
37.
ChaudharySBhattaNKLamsalMChaudhariRKKhanalB. Serum procalcitonin in bacterial & non-bacterial meningitis in children. BMC Pediatr. 2018;18(1):342.
38.
MoulinFRaymondJLorrotM, et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch Dis Child. 2001;84(4):332-336.
39.
AlejandreCGuitartCBalaguerM, et al. Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis. Eur J Pediatr. 2021;180(3):833-842.
40.
TsouPYRafaelJMaYK, et al. Diagnostic accuracy of procalcitonin for bacterial pneumonia in children—a systematic review and meta-analysis. Infect Dis (Lond). 2020;52(10):683-697.
41.
StockmannCAmpofoKKillpackJ, et al. Procalcitonin accurately identifies hospitalized children with low risk of bacterial community-acquired pneumonia. J Pediatric Infect Dis Soc. 2018;7(1):46-53.
42.
HoshinaTNanishiEKannoSNishioHKusuharaKHaraT. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis. J Infect Chemother. 2014;20(10):616-620.
43.
GunaratnamLCRobinsonJLHawkesMT. Systematic review and meta-analysis of diagnostic biomarkers for pediatric pneumonia. J Pediatric Infect Dis Soc. 2021;10:891-900.
44.
ThayyilSShenoyMHamalubaMGuptaAFraterJVerberIG. Is procalcitonin useful in early diagnosis of serious bacterial infections in children?Acta Paediatr. 2005;94(2):155-158.
45.
WaterfieldTManeyJALyttleMD, et al. Diagnostic test accuracy of point-of-care procalcitonin to diagnose serious bacterial infections in children. BMC Pediatr. 2020;20(1):487.
46.
SakyiSAEnimilAAduDK, et al. Individual and combined bioscore model of presepsin, procalcitonin, and high sensitive C-reactive protein as biomarkers for early diagnosis of paediatric sepsis. Heliyon. 2020;6(9):e04841.
47.
TrippellaGGalliLDe MartinoMLisiCChiappiniE. Procalcitonin performance in detecting serious and invasive bacterial infections in children with fever without apparent source: a systematic review and meta-analysis. Expert Rev Anti Infect Ther. 2017;15(11):1041-1057.
48.
NellisMEPonSGiambroneAE, et al. The diagnostic accuracy of serum procalcitonin for bacteremia in critically ill children. Infect Dis Clin Pract (Baltim Md). 2016;24(6):343-347.
49.
WuQNieJWuFXZouXLChenFY. Prognostic value of high-sensitivity c-reactive protein, procalcitonin and pancreatic stone protein in pediatric sepsis. Med Sci Monit. 2017;23:1533-1539.
50.
MahajanPGrzybowskiMChenX, et al. Procalcitonin as a marker of serious bacterial infections in febrile children younger than 3 years old. Acad Emerg Med. 2014;21(2):171-179.
